Linear Clinical Research Current Trials Menu

Compare Trials

LE180706 | DMTS Study 

Help us trial a new investigational treatment designed to be used in the management of post-operative pain. Dexmedetomidine is a sedative drug currently approved in Australia by the Therapeutic Goods Administration (TGA) for intravenous use. It is used in hospital settings to sedate patients prior to and during surgical procedures. We are investigating a transdermal drug delivery system (skin patch) to be used as an alternative to intravenous dosing to reduce post-operative pain.

You Get $2140! 

Visit Schedule

One in-house stay of 7 nights and 8 days

CohortIn-House Period 
Check-in D -1Check-out D7
823-Jun30-Jun 
  • Healthy Males and Females
  • Between 18 – 60 years of age
  • Body Mass Index (BMI) must be between 18.0 – 38.0 kg/m2 
  • Must be non-smokers (Max 2 cigarettes per month within the previous 6 months)
  • Must not have any existing chronic skin conditions (e.g. psoriasis, eczema, acne, rosacea), skin allergies, or sensitivities that could prevent the ability to wear a transdermal patch.
  • Must not have any scars, tattoos, burns, wounds, or excessive hair on the upper portion of the arm.
  • Must not have any clinically significant illness, disease, or severe allergies.
  • Must have a resting heart rate greater than 60 BPM

APPLY NOW

~

 

LE180802 | Macular Degeneration Study

Help us trial a new investigational treatment for dry age-related macular degeneration (AMD) and juvenile onset macular degeneration, known as Stargardt disease (STGD).

Macular degeneration is the leading cause of major vision loss in Australia and can affect the ability to read, drive, recognise faces and perform activities that require detailed vision. Participating in this trial means you’ll be supporting world leading research into treatment for this condition. There are currently no approved treatments available for dry AMD or SGTD.

You Get $4990! 

Appointment Schedule

18 day, 17 nights stay, 4 follow up appointments

 

CohortIN-HOUSEFOLLOW UP APPOINTMENTS
Check-InCheck-OutDay 18Day 19Day 21Day 28
21-Jul18-Jul19-Jul20-Jul22-Jul29-Jul

 

CohortIN-HOUSEFOLLOW UP APPOINTMENTS
Check-InCheck-OutDay 18Day 19Day 21Day 28
322-Jul8-Aug9-Aug10-Aug12-Aug19-Aug

  • Healthy Males and Females, aged between 18 and 65
  • Females must be of Non-Childbearing Potential (either Surgically Sterile or Postmenopausal)
  • Body Mass Index (BMI) between 18 – 30 kg/m2
  • Must be free from any clinically significant illness or disease
  • Participants must be non-smokers (Have not used any nicotine containing products in the last 28 days)
  • Participants must not have a history any severe reactions to medications
  • Participants must not have a history of Retinal Macular Edema or Stargardt Disease
  • Must not have received study drug in a previous trial

APPLY NOW

~

LE190203 | NET Study Extended

Help us trial a new investigational medication for the treatment of Neuroendocrine Tumors (NETs). NETs are tumours which develop from secretory cells found throughout the body. They are most commonly located in the gastrointestinal system, lung and pancreas but they can be found in other parts of the body as well.

You Get $4870! 

Visit Schedule

1 x in-house stays of  4 nights and 5 days and 2 x in-house stays of  3 nights and 4 days and with 10 x appointments

  • Healthy Males and Females (females must be surgically sterile or post-menopausal)
  • Between 18 – 55 years of age
  • Body Mass Index (BMI) must be between 18.0 – 32.0 kg/m2 
  • Must not have any clinically significant illness, disease, or severe allergies.

APPLY NOW

~

~

LE180901 | Asthma Study

This study needs healthy people with mild asthma– Help us research a medication for the treatment of Asthma!

You Get $5140! 

(this payment is based on completing all dates from one of the trial’s cohorts)

13 days in-house and 2 appointments

  • Healthy Males and Females between the ages of 18 and 55
  • BMI must be between 18 – 35 kg/m2
  • Females must be of Non-Childbearing Potential (either Surgically Sterile or Postmenopausal)
  • Must have diagnosis of mild asthma. (Documented evidence needed)
  • Must be non-smokers (for at least the last 6 months)

APPLY NOW

~

LL17035 | Malaria Study

Visit Schedule #Appointments Only

Participants will be required to attend 7 – 10 appointments. 

Part 1 Treatment (Week 1-52)Part 2 Follow-upPart 3 (Only if required)
Visit2345678910
Week14122452647689104
Hours2-324-54-54-54-51-21-21-2
Payment $ 490700810880210 210210

  *Participants who complete the study up to Week 64 will receive in total  *$2880! 

  • Healthy males and females between the ages of 18 and 55
  • Must agree to stay in contact with the study site for the duration of the study and up to Week 64 (Visit 7b). Have no current plans to move away from Perth for the duration of the study
  • Must maintain a diary throughout the study
  • No eye conditions or use of prescription eye drops

APPLY NOW